Circulating DNA Methylation Biomarkers for Diagnosis, Prognosis and Treatment Selection

Session 2: Circulating DNA Methylation Biomarkers for Diagnosis, Prognosis and Treatment Selection

8:10 AM – 9:10 AM

Moderator:
Gerhardt Attard, MD, PhD
University College London Cancer Institute, UK

Introduction
Gerhardt Attard, MD, PhD
University College London Cancer Institute, UK

Using 5-hydroxymethylcytosine Sequencing to Interrogate Biological Drivers of Advanced Prostate Cancer
Martin Sjöström, MD, PhD
University of California, San Francisco

Opportunities for Tracking the Prostate Cancer Methylome in Plasma
Gerhardt Attard, MD, PhD
University College London Cancer Institute, UK

Circulating Methylation Biomarkers for Neuroendocrine Prostate Cancer Differentiation
Francesca Demichelis, PhD
University of Trento, Italy

Live Session Discussion

9:10 AM – 9:15 AM     Please Return to the Virtual Lobby to Join the Next Session

82 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate